tiprankstipranks
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
US Market

Fulgent Genetics (FLGT) Financial Statements

Compare
1,626 Followers

Fulgent Genetics Financial Overview

Fulgent Genetics's market cap is currently $520.09M. The company's EPS TTM is $-1.415; its P/E ratio is ―; Fulgent Genetics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 283.47M$ 289.21M$ 618.97M$ 992.58M$ 421.71M
Gross Profit$ 107.22M$ 104.46M$ 366.90M$ 777.05M$ 331.90M
Operating Income$ -73.92M$ -72.69M$ 178.53M$ 675.95M$ 290.16M
EBITDA$ -73.92M$ -46.55M$ 221.59M$ 675.95M$ 290.16M
Net Income$ -42.71M$ -167.82M$ 143.40M$ 507.36M$ 214.31M
Balance Sheet
Cash & Short-Term Investments$ 258.11M$ 424.15M$ 852.88M$ 935.55M$ 431.87M
Total Assets$ 1.22B$ 1.24B$ 1.39B$ 1.28B$ 700.46M
Total Debt$ 412.00K$ 15.25M$ 20.64M$ 21.28M$ 15.85M
Net Debt$ -54.73M$ -82.22M$ -58.87M$ -143.61M$ -71.57M
Total Liabilities$ 90.81M$ 102.04M$ 116.18M$ 112.84M$ 131.07M
Stockholders' Equity$ 1.13B$ 1.14B$ 1.27B$ 1.17B$ 569.39M
Cash Flow
Free Cash Flow$ -19.25M$ 4.80M$ 234.75M$ 514.73M$ 104.12M
Operating Cash Flow$ 21.06M$ 27.00M$ 253.52M$ 538.58M$ 140.63M
Investing Cash Flow$ 38.90M$ 38.90M$ -261.31M$ -546.55M$ -326.44M
Financing Cash Flow$ -47.78M$ -47.78M$ -77.14M$ 85.39M$ 261.25M
Currency in USD

Fulgent Genetics Earnings and Revenue History

Fulgent Genetics Debt to Assets

Fulgent Genetics Cash Flow

Fulgent Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis